Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C–Mutant Non–Small Cell Lung Cancer
Lists
Only you see this
Abstract
Our findings suggest that EMT is a cause of both intrinsic and acquired resistance by activating the PI3K pathway in the presence of KRAS G12C inhibitor.
BibTeX
@inproceedings{adachi2020epithelial,
author = {Yuta Adachi and Kentaro Ito and Yuko Hayashi and Ryo Kimura and Tuan Zea Tan and Rui Yamaguchi and Hiromichi Ebi},
title = {{Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C–Mutant Non–Small Cell Lung Cancer}},
booktitle = {Clinical},
year = {2020},
doi = {10.1158/1078-0432.ccr-20-2077},
}Loading related content...